Efficacy and Safety Profiles of Surgical Resection in Patients with Metastatic Gynecologic Melanoma on Immune Checkpoint Inhibitors: A Retrospective Cohort Study

被引：0
|
作者：
Naderi-Azad, S. [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
BRITISH JOURNAL OF SURGERY | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
268
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of immune checkpoint inhibitors in elderly patients
    Mailly-Giacchetti, Leah
    Lopez-Trabada, Daniel
    Feldman, Judith
    Andre, Thierry
    Cohen, Romain
    BULLETIN DU CANCER, 2023, 110 (11) : 1204 - 1214
  • [22] Retrospective study of the efficacy and safety of fotemustine in 170 patients with metastatic melanoma
    Gonzalez-Larriba, J. L.
    Berrocal, A.
    Cerezuela, P.
    Galan, A.
    Jimenez, J.
    Moreno, A.
    Piulats, J. M.
    Fra, J.
    Crespo, G.
    Gonzalez, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
    Pan, Catherina X.
    Kim, Daniel Y.
    Lau, Charles B.
    Lau, William C.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (05) : 637 - 640
  • [24] Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
    Pan, Catherina X.
    Kim, Daniel Y.
    Lau, Charles B.
    Lau, William C.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    BRITISH JOURNAL OF DERMATOLOGY, 2023,
  • [25] Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis
    Schieber, Timothy
    Brunk, Kelly
    Clennon, Anna
    Woolbright, Benjamin L.
    Bantis, Leonidas E.
    Grauer, Dennis
    Cheng, Tiewei
    Abbasi, Saqib
    Wulff-Burchfield, Elizabeth
    Parikh, Rahul
    Li, Haoran
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [26] The Evaluation of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in Different Therapy Lines for Metastatic Melanoma: A Retrospective Study
    Okuda-Hiwatashi, Saki
    Amagai, Ryo
    Fujimura, Taku
    Kambayashi, Yumi
    Watanabe-Takahashi, Manami
    Yamazaki, Emi
    Tamabuchi, Erika
    Itabashi, Chisato
    Hashimoto, Akira
    Asano, Yoshihide
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [27] Immune Checkpoint Inhibitors' Effects on Calcified Aortic Plaques in Melanoma Survivors A Retrospective Cohort Study
    Turker, Isik
    Nair, Sangeeta
    Terry, James G.
    Huang, Shi
    Carr, John Jeffrey
    Moslehi, Javid J.
    Gupta, Deepak K.
    Alexander, Matthew R.
    Johnson, Douglas B.
    JACC: CARDIOONCOLOGY, 2023, 5 (04): : 536 - 538
  • [28] Efficacy and safety of immune checkpoint inhibitors in heavily pretreated patients with microsatellite stable metastatic colorectal cancer: a real-world retrospective study
    Zhao, Wensi
    Chen, Yongshun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (11): : 5378 - 5388
  • [29] The Feasibility and safety of surgery in Patients receiving immune checkpoint inhibitors: a retrospective study
    Elias, Alexandra W.
    Kasi, Pashtoon M.
    Stauffer, John A.
    Thiel, David D.
    Colibaseanu, Dorin T.
    Mody, Kabir
    Joseph, Richard W.
    Bagaria, Sanjay P.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [30] Incidence of New Primary Cutaneous Melanoma in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors A Single-Center Cohort Study
    Nanda, Japbani K.
    Dusza, Stephen W.
    Navarrete-Dechent, Cristian
    Liopyris, Konstantinos
    Marghoob, Ashfaq A.
    Marchetti, Michael A.
    JAMA DERMATOLOGY, 2021, 157 (01) : 79 - 83
12345